Friday, March 27, 2009 12:42:03 PM
yesterday I communicated with Mr. Davis. I think, it's interesting to read what he wrote to me. I'll tell it also to the group iof the wallstreet-online forum here in Germany. I hope there are some more investors involved in PDMI as Investolator and myself.
Kind regards and all the best for you all!
Sweeper
Dear ......
Since we last communicated, much has taken place at Paradigm Medical. I will attempt to catch you and the other shareholders up.
As you know, there was a reverse stock split approved by shareholders in December. That was necessary as painful as it was for the shareholders, it was necessary to move Paradigm back into the market. The organization had been left in a serious state and required some radical attention. We quickly began to develop a new relationship with some other investors other than the NIR Group. One's that would be as interested in the growth as in keeping the "patient" alive! We are in the final stages of receiving funding to sustain and grow the business.
I have been busy creating an extensive business plan that includes new re-organization, new management members and new corporate partners. The last effort will result in some new products that our distributive sales force in the International market and our new sales force in the US will be selling. We will return to the core of developing and finding the best instruments for early diagnosis of Glaucoma and other related associated diseases. We have set high expectations and our forecasts will reflect growth that has been sorely lacking for the past three years.
Finally, I apologize for our current Web Site. It will be totally overhauled.
Things are on the verge of improving......keep in touch and watch for the press releases beginning April 7th.
Stephen
Stephen L. Davis
2278 Oak Leaf Way
Sandy, UT 84092
(801) 571-5764 Residence
(801) 618-7954 Mobile
Time will tell, always does
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM